The current research evidence unanimously indicates that there is no benefit offered by convalescent plasma for the treatment of COVID-19.
Snapdeal will create a platform, Sanjeevani, to use its wide reach in India, including across smaller towns and cities to connect people.
Delhi CM Arvind Kejriwal said plasma stocks to treat COVID-19 patients are running very low and appealed to those who have recovered from the infectio